Highly profitable, high-growth telemedicine platform serving the German medical cannabis market
EBITDA
$1,008,000
Gross
$1,680,000
OTTIENI UNA VALUTAZIONE GRATUITA IN 24 ORE CLICK HERE X Dismiss
Global lower-middle market M&A Advisors
Countries in which we've closed transactions
Languages spoken by our Team
Total deals value
Global lower-middle market M&A Advisors
Countries in which we've closed transactions
Languages spoken by our Team
Total deals value
© 2026 MergersCorp M&A International.
© 2025 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities (“Members”) located throughout the world to provide Investment Banking, Corporate Finance, and Advisory Services and other client-related professional services. The Member Firms (“Members”) are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit our Disclaimer: https://mergerscorp.com/disclaimer. MergersCorp M&A International's franchising program is not offered to individuals or entities located in the United States.
The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.
U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.
Unique opportunity to acquire a rapidly scaling, fully remote telemedicine and digital prescription, GDPR-compliant platform operating under the EU cross-border framework. The business connects over 20,000 patients with licensed d ...
An exclusive opportunity to acquire 100% of the subsoil use rights for a strategic brownfield oil asset located in the prolific Aktobe Region. This project represents a high-upside redevelopment play, characterized by significan ...
A market-leading, profitable firm with over 30 years of deep expertise in Global Capability Center (GCC) strategy, setup, and transformation is being discreetly offered for sale. Keypoints A unique, proprietary D-Cap™ oper ...
Opportunity to acquire a premier, 75-year-old Saudi Arabian construction and industrial platform. This partnership is designed to create a regional EPC (Engineering, Procurement, and Construction) powerhouse by merging global ...
The company is a vertically integrated wine, sparkling wine, and cognac producer with a nationwide distribution network and owned production assets across key wine-growing regions of Kazakhstan. The Group combines large-scale pro ...
The Arms & Ammunition plant, located just three hours northwest of Bucharest, is a rare strategic asset. Formerly one of Europe’s largest facilities, its true value lies not only in its infrastructure but in its construction ...
The organization provides cross-border payment solutions. Its operations are always managed alongside a licensed partner operating under official Central Bank licenses. This solution is currently operational in Kenya, Thailand, Ph ...
This is a pioneer in peer-to-peer (P2P) cryptocurrency trading and consultancy, dedicated to creating a secure, transparent, and accessible crypto market. Led by an experienced trader with deep expertise in the global cryptocurren ...
The company is an experienced consulting and trading firm specializing in ultra-fine copper powder. The focus is on copper powder with a purity of at least 99.999%. The firm acts as the interface between the buyer and seller , wor ...
Unique opportunity to acquire a rapidly scaling, fully remote telemedicine and digital prescription, GDPR-compliant platform operating under the EU cross-border framework. The business connects over 20,000 patients with licensed doctors and pharmacies in Germany
Operates under EU cross-border telemedicine framework (Physicians licensed in Germany & Poland). GDPR-compliant platform. No direct cannabis handling license required.
Cyprus-based company operates a fully digital telemedicine platform, enabling remote consultations and digital prescriptions
Launched in 2024, the platform has served approximately 20,000 patients and processed over 6,500 prescriptions per month
Focused on deep process optimization to ensure scalability before launching targeted marketing campaigns, including Facebook advertising and affiliate marketing, and continues to implement new features to enhance user experience
Profitable business with margins exceeding 60%, a current revenue run rate of ~€140,000 per month, and a forecasted €1.5M by year-end, reflecting ~20% annual growth
Income is generated through patient appointment bookings, marketing services for pharmacies, partnerships with leading producers, and white-label product offerings.
Operates efficiently with ~12 staff/freelancers, leveraging front-end and back-end freelance specialists
Automated workflows reduce doctor consultation time by 90%, and the platform supports white-label functionality for rapid B2B expansion
Projected annual growth of 15–20% is driven by rising patient demand and recent liberalization of the German cannabis market
Seeking full sale and includes the going concern business, intellectual property, brand, patient database, and software codebase
© 2025 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities (“Members”) located throughout the world to provide Investment Banking, Corporate Finance, and Advisory Services and other client-related professional services. The Member Firms (“Members”) are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit our Disclaimer: https://mergerscorp.com/disclaimer. MergersCorp M&A International's franchising program is not offered to individuals or entities located in the United States.
The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.
U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.
This website is operated by MergersUS Inc a US Corporation with registered office at




